Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress [Yahoo! Finance]
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Genmab Announces Financial Results for the First Quarter of 2024 [Yahoo! Finance]
Genmab Announces Financial Results for the First Quarter of 2024